12:00 AM
 | 
Jul 10, 1995
 |  BC Week In Review  |  Company News  |  Deals

Amersham International plc deal

Amersham's United States Biochemical Corp. subsidiary received an exclusive worldwide license from Harvard Medical School to a technology to develop DNA polymerases for use in DNA sequencing. Scientists at Harvard had previously developed Sequenase, a...

Read the full 155 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >